1. ABSTRACT (PROJECT 1) Gene transfer is a potential strategy to treat CF airways disease, yet we still lack answers to important questions to any gene transfer approach. What percentage of CF airway epithelial cells must be targeted and at what expression level is needed to correct relevant ion transport defects? What are the key CF host defense defects? Can we rescue those defects? Will targeting airway surface epithelia in vivo rescue host defense? Clinical CF lung disease? Our program made advances in three areas that allow us to answer these questions. First, we developed a model of CF in pigs. Within months of birth, they develop features of CF lung disease. Second, we discovered that loss of CFTR impairs two key respiratory host defense mechanisms, mucociliary transport (MCT) and antibacterial activity in airway surface liquid (ASL). Impaired CFTR-mediated HCO3- secretion that results in abnormally acidic ASL causes both of these defects. Third, we developed viral vectors: AAV evolved to infect airway epithelia, and GP64-pseudotyped FIV that can deliver CFTR cDNA to airway epithelia. Our preliminary data indicate that these vectors generate airway epithelial HCO3- secretion and correct the acidic ASL pH. Now is the time to answer questions that have nagged the field since we first began thinking about gene therapy. Here we propose three specific aims that will inform strategies for CF gene transfer.
Aim 1. What factors determine whether gene transfer to pig and human CF airway epithelia in vitro rescues anion secretion and host defense properties? We will investigate the relationships between transduction and expression data (the % of cells expressing CFTR, the level of CFTR expression) and the physiological consequences.
Aim 2. Will CFTR gene transfer to CF airway surface epithelia correct ASL pH, bacterial killing, and MCT defects in vivo? Aim 3. Will gene transfer to airway surface epithelia prevent the airway inflammation, infection, and remodeling associated with early CF lung disease? These data may help us understand the relative importance of the CF host defense defects, will suggest whether targeting surface epithelia has clinical benefit, and will guide future gene transfer approaches.

Public Health Relevance

(PROJECT 1) Our recent discoveries indicate that CF lung disease is caused by defects in two key host defenses of the lungs: mucociliary transport (MCT) and antibacterial activity in airway surface liquid (ASL). Both of these defects are related to impaired CFTR mediated HCO3- secretion, resulting in abnormally acidic ASL and submucosal gland secretions. The series of experiments proposed will help us understand the relative importance of these CF host defense defects, will suggest whether targeting surface epithelia has clinical benefit, and will guide future gene transfer approaches.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL051670-23
Application #
9279224
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Sheridan, John T
Project Start
Project End
Budget Start
2017-06-01
Budget End
2018-05-31
Support Year
23
Fiscal Year
2017
Total Cost
$313,180
Indirect Cost
$107,816
Name
University of Iowa
Department
Type
Domestic Higher Education
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52246
Meyerholz, David K; Sieren, Jessica C; Beck, Amanda P et al. (2018) Approaches to Evaluate Lung Inflammation in Translational Research. Vet Pathol 55:42-52
Rosen, Bradley H; Evans, T Idil Apak; Moll, Shashanna R et al. (2018) Infection Is Not Required for Mucoinflammatory Lung Disease in CFTR-Knockout Ferrets. Am J Respir Crit Care Med 197:1308-1318
Mao, Suifang; Shah, Alok S; Moninger, Thomas O et al. (2018) Motile cilia of human airway epithelia contain hedgehog signaling components that mediate noncanonical hedgehog signaling. Proc Natl Acad Sci U S A 115:1370-1375
Montoro, Daniel T; Haber, Adam L; Biton, Moshe et al. (2018) A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature 560:319-324
Lynch, Thomas J; Anderson, Preston J; Rotti, Pavana G et al. (2018) Submucosal Gland Myoepithelial Cells Are Reserve Stem Cells That Can Regenerate Mouse Tracheal Epithelium. Cell Stem Cell 22:653-667.e5
Meyerholz, David K; Stoltz, David A; Gansemer, Nick D et al. (2018) Lack of cystic fibrosis transmembrane conductance regulator disrupts fetal airway development in pigs. Lab Invest 98:825-838
Gray, Robert D; Hardisty, Gareth; Regan, Kate H et al. (2018) Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis. Thorax 73:134-144
Thornell, Ian M; Li, Xiaopeng; Tang, Xiao Xiao et al. (2018) Nominal carbonic anhydrase activity minimizes airway-surface liquid pH changes during breathing. Physiol Rep 6:
Reznikov, Leah R; Meyerholz, David K; Abou Alaiwa, Mahmoud et al. (2018) The vagal ganglia transcriptome identifies candidate therapeutics for airway hyperreactivity. Am J Physiol Lung Cell Mol Physiol 315:L133-L148
Meyerholz, David K; Beck, Amanda P; Goeken, J Adam et al. (2018) Glycogen depletion can increase the specificity of mucin detection in airway tissues. BMC Res Notes 11:763

Showing the most recent 10 out of 184 publications